During Trial Services
Machine learning assisted clinical trials by choosing patients at higher risk of disability progression or specific biological profiles to choose the best treatment for patients.
Regular internal audit for ISO 9001, and FDA 21 Part 11 Compliance.
Data-Driven Patient Staging
Stratifying patients into groups according to the stage of the disease progression, as an important step toward individualised decision making in research studies, clinical trials, and in the near future, clinical practice.
Machine Learning Prognosticating
Using routinely available data to detect high risk patients who may benefit from stronger treatments or clinical trials of high efficacy treatments, while minimising adverse events for those with milder disease course.